Which populations are most vulnerable to Alzheimer’s disease and why?

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

  1. Satizabal C, et al. N Engl J Med 2016;374:523–32.
  2. Hill C, et al. Ethn Dis 2015;25:245–54.
  3. Mayeda E, et al. Alzheimers Dement 2016;12:216–24.
  4. Gilsanz P, et al. Alzheimers Dement 2019;15:497–505.
  5. Weuve J, et al. Epidemiology 2018;29:151–9.
  6. Mayeda E, et al. Alzheimer Dis Assoc Disord 2015;29:206–12.
  7. Gilsanz P, et al. JAMA Neurol 2017;74:1056–62.
  8. Ward J, et al. Ann Epidemiol 2019;29:1–7.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country